Market Overview

Lightning Round: Jim Cramer Weighs In On Bristol-Myers Squibb, Mazor Robotics And More

Share:
Related BMY
The Week Ahead: Trump Goes To London, Big Banks Herald Earnings Season's Return
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials
Venture Capital Deals Of The Week: SoftBank Circles $1B AI Investment (Seeking Alpha)
Related
Cantor Fitzgerald Taps Spinal Stocks: 4 Top Picks
Benzinga's Top Upgrades, Downgrades For June 1, 2018
Rounds Report: TransEnterix Caught A Break On A Down Day (Seeking Alpha)

Jim Cramer spoke on CNBC's "Mad Money Lightning Round" about Bristol-Myers Squibb Co (NYSE: BMY). He said the stock came back and made a new high despite losing a bunch head-to-heads against Keytruda. He likes the stock.

Cramer advised his viewer to hold Mazor Robotics Ltd - ADR (NASDAQ: MZOR) because it's going to be the next Intuitive Surgical, Inc. (NASDAQ: ISRG). He added that problems the company had with Israeli government have passed.

Himax Technologies, Inc. (ADR) (NASDAQ: HIMX) is a speculative stock, thinks Cramer.

Iridium Communications Inc (NASDAQ: IRDM) had a good comeback, but Cramer doesn't see anything that should have driven the stock up so much.

Cramer likes Zagg Inc (NASDAQ: ZAGG) and he thinks there's a lot to the company. He also likes devices that give us more battery life.

Cramer also likes McCormick & Company (NYSE: MKC). He likes its recent acquisition.

Posted-In: CNBC mad money Lightning Round Jim CramerMedia

 

Related Articles (HIMX + BMY)

View Comments and Join the Discussion!